Skip to main content

CORRECTION article

Front. Chem., 18 June 2024
Sec. Medicinal and Pharmaceutical Chemistry
Volume 12 - 2024 | https://doi.org/10.3389/fchem.2024.1443822

Corrigendum: HSA-nanobinders crafted from bioresponsive prodrugs for combined cancer chemoimmunotherapy–an in vitro exploration

This article is a correction to:

  1. HSA-nanobinders crafted from bioresponsive prodrugs for combined cancer chemoimmunotherapy–an in vitro exploration

    1. Read original article
Matilde Tubertini,Matilde Tubertini1,2Luca MenilliLuca Menilli3Celeste MilaniCeleste Milani4Cecilia MartiniCecilia Martini1Maria Luisa NavacchiaMaria Luisa Navacchia1Marta NugnesMarta Nugnes5Manuela BartoliniManuela Bartolini5Marina NaldiMarina Naldi5Daniele TedescoDaniele Tedesco1Elisa MartellaElisa Martella1Andrea GuerriniAndrea Guerrini1Claudia FerroniClaudia Ferroni1Francesca Moret Francesca Moret4*Greta Varchi Greta Varchi1*
  • 1Institute for Organic Synthesis and Photoreactivity (ISOF), National Research Council of Italy (CNR), Bologna, Italy
  • 2Department of Science and High Technology, University of Insubria, Como, Italy
  • 3Pharmacy Unit, Veneto Institute of Oncology IOV-IRCSS, Padua, Italy
  • 4Department of Biology (DiBio), University of Padova, Padua, Italy
  • 5Department of Pharmacy and Biotechnology (FaBiT), University of Bologna, Bologna, Italy

A Corrigendum on
HSA-nanobinders crafted from bioresponsive prodrugs for combined cancer chemoimmunotherapy-an in vitro exploration

by Tubertini M, Menilli L, Milani C, Martini C, Navacchia ML, Nugnes M, Bartolini M, Naldi M, Tedesco D, Martella E, Guerrini A, Ferroni C, Moret F and Varchi G (2024). Front. Chem. 12:1378233. doi: 10.3389/fchem.2024.1378233

In the published article, there was an error in the Affiliation. Matilde Tubertini’s second affiliation was missing. The correct affiliations appear above.

The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.

Publisher’s note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.

Keywords: prodrugs, chemotherapy, IDO1 inhibition, endogenous human serum albumin, carrier-free nanoparticles, truncated evans blue, triple-negative breast cancer

Citation: Tubertini M, Menilli L, Milani C, Martini C, Navacchia ML, Nugnes M, Bartolini M, Naldi M, Tedesco D, Martella E, Guerrini A, Ferroni C, Moret F and Varchi G (2024) Corrigendum: HSA-nanobinders crafted from bioresponsive prodrugs for combined cancer chemoimmunotherapy–an in vitro exploration. Front. Chem. 12:1443822. doi: 10.3389/fchem.2024.1443822

Received: 04 June 2024; Accepted: 05 June 2024;
Published: 18 June 2024.

Approved by:

Frontiers Editorial Office, Frontiers Media SA, Switzerland

Copyright © 2024 Tubertini, Menilli, Milani, Martini, Navacchia, Nugnes, Bartolini, Naldi, Tedesco, Martella, Guerrini, Ferroni, Moret and Varchi. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

*Correspondence: Greta Varchi, greta.varchi@isof.cnr.it; Francesca Moret, francesca.moret@unipd.it

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.